Shield Therapeutics (STX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

42.00p
   
  • Change Today:
      2.00p
  • 52 Week High: 133.62
  • 52 Week Low: 33.00
  • Currency: UK Pounds
  • Shares Issued: 215.89m
  • Volume: 717,921
  • Market Cap: 90.67m

STX Overview

Shield is a de-risked commercial stage, pharmaceutical company focused on addressing iron deficiency in adults with or without anaemia. Our clear purpose is to develop products that help patients become people again, enabling them to enjoy the things that make a difference in their everyday lives.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -20.7% -472.5%
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 8.7 18.8
Pr/Book 3.0  
Latest F'cast
Revenue 1343.1% -53.6%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

STX Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-16 0.30 (15.60) (8.75)p n/a n/a n/a n/a 0.0%
31-Dec-17 0.64 (20.99) (16.52)p n/a n/a n/a n/a 0.0%
31-Dec-18 11.88 (5.15) (1.94)p n/a n/a n/a n/a 0.0%
31-Dec-19 0.72 (9.07) (7.77)p n/a n/a n/a n/a 0.0%
31-Dec-20 10.39 (1.89) (1.94)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

STX Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-21 4.83 (22.81) (11.39)p n/a n/a n/a n/a 0.0%
31-Dec-22 29.18 (8.17) (3.45)p n/a n/a n/a n/a 0.0%

Copyright © 2021 FactSet Research Systems Inc. All rights reserved.

STX Company Announcements

PDMR Transaction Notification 23-Aug-2021 07:00 RNS
Half-year Report 17-Aug-2021 07:00 RNS
Licence agreement secured in Republic of Korea 12-Aug-2021 07:00 RNS

Latest STX Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

STX Market Data

Currency UK Pounds
Share Price 42.00p
Change Today 2.00p
% Change 5.00 %
52 Week High 133.62
52 Week Low 33.00
Volume 717,921
Shares Issued 215.89m
Market Cap 90.67m

STX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
38.41% below the market average38.41% below the market average38.41% below the market average38.41% below the market average38.41% below the market average
60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average
Price Trend
58.48% below the market average58.48% below the market average58.48% below the market average58.48% below the market average58.48% below the market average
67.74% below the sector average67.74% below the sector average67.74% below the sector average67.74% below the sector average67.74% below the sector average
Income Not Available
Growth
67.92% above the market average67.92% above the market average67.92% above the market average67.92% above the market average67.92% above the market average
77.78% above the sector average77.78% above the sector average77.78% above the sector average77.78% above the sector average77.78% above the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

STX Dividends

No dividends found

Trades for 24-Sep-2021

Time Volume / Share Price
17:09 11,372 @ 42.00p
16:28 4,900 @ 42.20p
16:23 3,545 @ 42.20p
15:54 12,000 @ 42.20p
15:46 10,000 @ 42.20p

Top of Page